UV irradiation of immunized mice induces type 1 regulatory T cells that suppress tumor antigen specific cytotoxic T lymphocyte responses
Masaaki Toda
Department of Cellular and Molecular Immunology, Mie Graduate School of Medicine, Tsu, Japan
Search for more papers by this authorLinan Wang
Department of Cellular and Molecular Immunology, Mie Graduate School of Medicine, Tsu, Japan
Department of Cancer Vaccine, Mie Graduate School of Medicine, Tsu, Japan
Search for more papers by this authorSuguru Ogura
Department of Cellular and Molecular Immunology, Mie Graduate School of Medicine, Tsu, Japan
Search for more papers by this authorMie Torii
Department of Cellular and Molecular Immunology, Mie Graduate School of Medicine, Tsu, Japan
Search for more papers by this authorMakoto Kurachi
Department of Molecular Preventive Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
Search for more papers by this authorKazuhiro Kakimi
Department of Immunotherapeutics (Medinet), Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
Search for more papers by this authorHiroyoshi Nishikawa
Department of Cancer Vaccine, Mie Graduate School of Medicine, Tsu, Japan
Search for more papers by this authorKouji Matsushima
Department of Molecular Preventive Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
Search for more papers by this authorHiroshi Shiku
Department of Cancer Vaccine, Mie Graduate School of Medicine, Tsu, Japan
Department of Immuno-Gene Therapy, Mie Graduate School of Medicine, Tsu, Japan
Search for more papers by this authorKagemasa Kuribayashi
Department of Cellular and Molecular Immunology, Mie Graduate School of Medicine, Tsu, Japan
Search for more papers by this authorCorresponding Author
Takuma Kato
Department of Cellular and Molecular Immunology, Mie Graduate School of Medicine, Tsu, Japan
Tel.: +81-59-231-5380; Fax: +81-59-231-5276
Department of Cellular and Molecular Immunology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie 514-8507, JapanSearch for more papers by this authorMasaaki Toda
Department of Cellular and Molecular Immunology, Mie Graduate School of Medicine, Tsu, Japan
Search for more papers by this authorLinan Wang
Department of Cellular and Molecular Immunology, Mie Graduate School of Medicine, Tsu, Japan
Department of Cancer Vaccine, Mie Graduate School of Medicine, Tsu, Japan
Search for more papers by this authorSuguru Ogura
Department of Cellular and Molecular Immunology, Mie Graduate School of Medicine, Tsu, Japan
Search for more papers by this authorMie Torii
Department of Cellular and Molecular Immunology, Mie Graduate School of Medicine, Tsu, Japan
Search for more papers by this authorMakoto Kurachi
Department of Molecular Preventive Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
Search for more papers by this authorKazuhiro Kakimi
Department of Immunotherapeutics (Medinet), Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
Search for more papers by this authorHiroyoshi Nishikawa
Department of Cancer Vaccine, Mie Graduate School of Medicine, Tsu, Japan
Search for more papers by this authorKouji Matsushima
Department of Molecular Preventive Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
Search for more papers by this authorHiroshi Shiku
Department of Cancer Vaccine, Mie Graduate School of Medicine, Tsu, Japan
Department of Immuno-Gene Therapy, Mie Graduate School of Medicine, Tsu, Japan
Search for more papers by this authorKagemasa Kuribayashi
Department of Cellular and Molecular Immunology, Mie Graduate School of Medicine, Tsu, Japan
Search for more papers by this authorCorresponding Author
Takuma Kato
Department of Cellular and Molecular Immunology, Mie Graduate School of Medicine, Tsu, Japan
Tel.: +81-59-231-5380; Fax: +81-59-231-5276
Department of Cellular and Molecular Immunology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie 514-8507, JapanSearch for more papers by this authorAbstract
We previously showed that exposure to UV radiation after immunization suppresses Th1 and Th2 immune responses, leading to impaired Ab and allo-immune responses, but the impact of UV radiation after immunization on anti-tumor immune responses mediated by tumor-specific CD8+ T cell responses remains less clear. Furthermore, the exact phenotypic and functional characteristics of regulatory T cell population responsible for the UV-induced immunosuppression still remain elusive. Using the MBL-2 lymphoma cell line engineered to express OVA as a surrogate tumor Ag, here we demonstrate that UV irradiation after tumor Ag-immunization suppresses the anti-tumor immune response in a manner dependent on the immunizing Ag. This suppression was mediated by interleukin (IL)-10 released from CD4+CD25+ T cells, by which impaired the induction of cytotoxic T lymphocytes (CTL) able to kill Ag-expressing tumor cells. In addition, we generated a panel of T cell clones from UV-irradiated and non-irradiated mice, and all of the clones derived from UV-irradiated mice had a Tr1-type regulatory T cell phenotype with expression of IL-10 and c-Maf, but not Foxp3. These Tr1-type regulatory T cell clones suppressed tumor rejection in vivo as well as Th cell activation in vitro in an IL-10 dependent manner. Given that suppression of Ag-specific CTL responses can be induced in Ag-sensitized mice by UV irradiation, our results may imply that exposure to UV radiation during premalignant stage induces tumor-Ag specific Tr1 cells that mediate tumor-Ag specific immune suppression resulting in the promotion of tumor progression.
References
- 1 Brash DE, Ziegler A, Jonason AS, Simon JA, Kunala S, Leffell DJ. Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion. J Investig Dermatol Symp Proc 1996; 1: 136–42.
- 2 Ullrich SE. Mechanisms underlying UV-induced immune suppression. Mutat Res 2005; 571: 185–205.
- 3 Kripke ML. Antigenicity of murine skin tumors induced by ultraviolet light. J Natl Cancer Inst 1974; 53: 1333–6.
- 4 Kripke ML. Latency, histology, and antigenicity of tumors induced by ultraviolet light in three inbred mouse strains. Cancer Res 1977; 37: 1395–400.
- 5 Grabbe S, Bruvers S, Lindgren AM, Hosoi J, Tan KC, Granstein RD. Tumor antigen presentation by epidermal antigen-presenting cells in the mouse: modulation by granulocyte-macrophage colony-stimulating factor, tumor necrosis factor alpha, and ultraviolet radiation. J Leukoc Biol 1992; 52: 209–17.
- 6 Grabbe S, Bruvers S, Gallo RL, Knisely TL, Nazareno R, Granstein RD. Tumor antigen presentation by murine epidermal cells. J Immunol 1991; 146: 3656–61.
- 7 Beissert S, Granstein RD. UV-induced cutaneous photobiology. Crit Rev Biochem Mol Biol 1996; 31: 381–404.
- 8 Waltz P, Chodick G. Assessment of ecological regression in the study of colon, breast, ovary, non-Hodgkin's lymphoma, or prostate cancer and residential UV. Eur J Cancer Prev 2008; 17: 279–86.
- 9 Zhang Y, Holford TR, Leaderer B, Boyle P, Zhu Y, Wang R, Zou K, Zhang B, Wise JP, Sr., Qin Q, Kilfoy B, Han J, et al. Ultraviolet radiation exposure and risk of non-Hodgkin's lymphoma. Am J Epidemiol 2007; 165: 1255–64.
- 10 Sleijffers A, Garssen J, Van Loveren H. Ultraviolet radiation, resistance to infectious diseases, and vaccination responses. Methods 2002; 28: 111–21.
- 11 Norval M, El-Ghorr AA. UV-induced immunosuppression in virus infections. Mutat Res 1998; 422: 131–8.
- 12 Oliven A, Shechter Y. Extracorporeal photopheresis: a review. Blood Rev 2001; 15: 103–8.
- 13 Bohm M, Luger TA, Schneider M, Schwarz T, Kuhn A. New insight into immunosuppression and treatment of autoimmune diseases. Clin Exp Rheumatol 2006; 24: 67–71.
- 14 Aubin F, Mousson C. Ultraviolet light-induced regulatory (suppressor) T cells: an approach for promoting induction of operational allograft tolerance? Transplantation 2004; 77: S29–31.
- 15 Hori T, Kuribayashi K, Uemoto S, Saito K, Wang L, Torii M, Shibutani S, Taniguchi K, Yagi S, Iida T, Yamamoto C, Kato T. Alloantigen-specific prolongation of allograft survival in recipient mice treated by alloantigen immunization following ultraviolet-B irradiation. Transplant Immunol 2008; 19: 45–54.
- 16 Wang L, Saito K, Toda M, Hori T, Torii M, Ma N, Katayama N, Shiku H, Kuribayashi K, Kato T. UV irradiation after immunization induces type 1 regulatory T cells that suppress Th2-type immune responses via secretion of IL-10. Immunobiology 2010; 215: 124–32.
- 17 Moodycliffe AM, Nghiem D, Clydesdale G, Ullrich SE. Immune suppression and skin cancer development: regulation by NKT cells. Nat Immunol 2000; 1: 521–5.
- 18 Maeda A, Beissert S, Schwarz T, Schwarz A. Phenotypic and functional characterization of ultraviolet radiation-induced regulatory T cells. J Immunol 2008; 180: 3065–71.
- 19 Ghoreishi M, Dutz JP. Tolerance induction by transcutaneous immunization through ultraviolet-irradiated skin is transferable through CD4+CD25+ T regulatory cells and is dependent on host-derived IL-10. J Immunol 2006; 176: 2635–44.
- 20 Loser K, Mehling A, Loeser S, Apelt J, Kuhn A, Grabbe S, Schwarz T, Penninger JM, Beissert S. Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nat Med 2006; 12: 1372–9.
- 21 Wang L, Toda M, Saito K, Hori T, Horii T, Shiku H, Kuribayashi K, Kato T. Post-immune UV-irradiation induces Tr1-like regulatory T cells that suppress humoral immune responses. Int Immunol 2008; 20: 57–70.
- 22 Nghiem DX, Kazimi N, Clydesdale G, Ananthaswamy HN, Kripke ML, Ullrich SE. Ultraviolet A radiation suppresses an established immune response: implications for sunscreen design. J Invest Dermatol 2001; 117: 1193–9.
- 23 Nghiem DX, Kazimi N, Mitchell DL, Vink AA, Ananthaswamy HN, Kripke ML, Ullrich SE. Mechanisms underlying the suppression of established immune responses by ultraviolet radiation. J Invest Dermatol 2002; 119: 600–8.
- 24 Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell 2008; 133: 775–87.
- 25 Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting. Immunity 2004; 21: 137–48.
- 26 Nishikawa H, Sato E, Briones G, Chen LM, Matsuo M, Nagata Y, Ritter G, Jager E, Nomura H, Kondo S, Tawara I, Kato T, et al. In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccines. J Clin Invest 2006; 116: 1946–54.
- 27 Kato T, Tada-Oikawa S, Takahashi K, Saito K, Wang L, Nishio A, Hakamada-Taguchi R, Kawanishi S, Kuribayashi K. Endocrine disruptors that deplete glutathione levels in APC promote Th2 polarization in mice leading to the exacerbation of airway inflammation. Eur J Immunol 2006; 36: 1199–209.
- 28 Nishikawa H, Kato T, Tawara I, Takemitsu T, Saito K, Wang L, Ikarashi Y, Wakasugi H, Nakayama T, Taniguchi M, Kuribayashi K, Old LJ, et al. Accelerated chemically induced tumor development mediated by CD4+CD25+ regulatory T cells in wild-type hosts. Proc Natl Acad Sci U S A 2005; 102: 9253–7.
- 29 Kato T, Uchikawa R, Yamada M, Arizono N, Oikawa S, Kawanishi S, Nishio A, Nakase H, Kuribayashi K. Environmental pollutant tributyltin promotes Th2 polarization and exacerbates airway inflammation. Eur J Immunol 2004; 34: 1312–21.
- 30 Matsuzaki J, Tsuji T, Chamoto K, Takeshima T, Sendo F, Nishimura T. Successful elimination of memory-type CD8+ T cell subsets by the administration of anti-Gr-1 monoclonal antibody in vivo. Cell Immunol 2003; 224: 98–105.
- 31 Takeuchi Y, Nishimura T, Gao XH, Watanabe K, Akatsuka A, Shinkai Y, Okumura K, Habu S. Perforin is expressed in CTL populations generated in vivo. Immunol Lett 1992; 31: 183–7.
- 32 Pot C, Jin H, Awasthi A, Liu SM, Lai CY, Madan R, Sharpe AH, Karp CL, Miaw SC, Ho IC, Kuchroo VK. Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells. J Immunol 2009; 183: 797–801.
- 33 Bevan MJ. Helping the CD8+ T-cell response. Nat Rev Immunol 2004; 4: 595–602.
- 34 Castellino F, Germain RN. Cooperation between CD4+ and CD8+ T cells: when, where, and how. Annu Rev Immunol 2006; 24: 519–40.
- 35 Krasteva M, Aubin F, Laventurier S, Kehren J, Assossou O, Kanitakis J, Kaiserlian D, Nicolas JF. MHC class II-KO mice are resistant to the immunosuppressive effects of UV light. Eur J Dermatol 2002; 12: 10–9.
- 36 Loser K, Apelt J, Voskort M, Mohaupt M, Balkow S, Schwarz T, Grabbe S, Beissert S. IL-10 controls ultraviolet-induced carcinogenesis in mice. J Immunol 2007; 179: 365–71.
- 37 Rana S, Byrne SN, MacDonald LJ, Chan CY, Halliday GM. Ultraviolet B suppresses immunity by inhibiting effector and memory T cells. Am J Pathol 2008; 172: 993–1004.
- 38 Fisher MS, Kripke ML. Further studies on the tumor-specific suppressor cells induced by ultraviolet radiation. J Immunol 1978; 121: 1139–44.
- 39 Fisher MS, Kripke ML. Suppressor T lymphocytes control the development of primary skin cancers in ultraviolet-irradiated mice. Science 1982; 216: 1133–4.
- 40 Beissert S, Hosoi J, Kuhn R, Rajewsky K, Muller W, Granstein RD. Impaired immunosuppressive response to ultraviolet radiation in interleukin-10-deficient mice. J Invest Dermatol 1996; 107: 553–7.
- 41 Shreedhar V, Giese T, Sung VW, Ullrich SE. A cytokine cascade including prostaglandin E2, IL-4, and IL-10 is responsible for UV-induced systemic immune suppression. J Immunol 1998; 160: 3783–9.
- 42 Cao S, Liu J, Song L, Ma X. The protooncogene c-Maf is an essential transcription factor for IL-10 gene expression in macrophages. J Immunol 2005; 174: 3484–92.
- 43 Xu J, Yang Y, Qiu G, Lal G, Wu Z, Levy DE, Ochando JC, Bromberg JS, Ding Y. c-Maf regulates IL-10 expression during Th17 polarization. J Immunol 2009; 182: 6226–36.
- 44 Apetoh L, Quintana FJ, Pot C, Joller N, Xiao S, Kumar D, Burns EJ, Sherr DH, Weiner HL, Kuchroo VK. The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nat Immunol 2010; 11: 854–61.
- 45 Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, Roncarolo MG. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997; 389: 737–42.
- 46 Roncarolo MG, Gregori S, Battaglia M, Bacchetta R, Fleischhauer K, Levings MK. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev 2006; 212: 28–50.
- 47 Vieira PL, Christensen JR, Minaee S, J. ONE, Barrat FJ, Boonstra A, Barthlott T, Stockinger B, Wraith DC, O'Garra A. IL-10 secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells. J Immunol 2004; 172: 5986–93.
- 48 Zhang X, Huang H, Yuan J, Sun D, Hou W-S, Gordon J, Xiang J. CD4−CD8− dendritic cells prime CD4+ T regulatory 1 cells to suppress antitumor immunity. J Immunol 2005; 175: 2931–7.
- 49 Hao S, Yuan J, Xu S, Munegowda MA, Deng Y, Gordon J, Xing Z, Xiang J. Antigen specificity acquisition of adoptive CD4+ regulatory T cells via acquired peptide-MHC class I complexes. J Immunol 2008; 181: 2428–37.